PMDA drug package insert
マスーレッド錠5mg
PMDA Prescription drug · バイエル薬品株式会社 · package insert Aug 31, 2022
Key facts
| Brand names | マスーレッド錠5mg, マスーレッド錠12.5mg, マスーレッド錠25mg, マスーレッド錠75mg |
|---|---|
| Nonproprietary names | モリデュスタットナトリウム |
| Companies | 製造販売元／バイエル薬品株式会社 |
| Product type | Prescription drug |
| Therapeutic category | HIF-PH阻害薬; 腎性貧血治療薬 |
| Therapeutic category codes | 873999 |
| YJ codes | 3999055F1022, 3999055F2029, 3999055F3025, 3999055F4021 |
| Approval numbers | 30300AMX00020000, 30300AMX00021000, 30300AMX00022000, 30300AMX00024000 |
| Package insert edition | 第4版 |
| Package insert date | Aug 31, 2022 |
| PMDA document key | 630004_3999055F1022_1 |
| PMDA company code | 630004 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: